semaglutide safety concerns Is Safe? What You Need to Know Two-year effects of semaglutide in

GLP-1 (glucagon-like peptide-1) shots are a type of injectable medication used to treat type 2 diabetes

Because it can increase urination, morning dosing may be more comfortable for many people

Both peptides also show overlapping anti-inflammatory signals in separate studies, with each associated with reduced pro-inflammatory cytokines such as IL-6 and TNF-alpha in animal models

It may be particularly beneficial for individuals who struggle to achieve adequate blood sugar control with existing therapies or who are at high risk of cardiovascular events

A major player that moves in the next 12 months can set the terms